Overview
At Syner-G BioPharma Group, we fully recognize that each client and each project is unique, and the CMC requirements vary depending on several factors such as complexity of the molecule, formulation, indication, patient population, and state of development. With patient safety and regulatory compliance as the primary objectives, Syner-G helps to design and implement science and risk-based, phase-appropriate CMC solutions to expeditiously advance your drug during development and/or sustain the the commercial supply chain post-approval. Our CMC 360 business units operate in an integrated fashion to ensure that the solutions we provide fully conform to the scientific standards and regulatory requirements.